Literature DB >> 9316943

Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group.

S Whittier1, K Olivier, P Gilligan, M Knowles, P Della-Latta.   

Abstract

An improved decontamination method has been demonstrated to reduce overgrowth of mycobacterial media by Pseudomonas aeruginosa and allow the successful recovery of nontuberculous mycobacteria (NTM) from cystic fibrosis (CF) patients. Twenty microbiology laboratories participating in a multicenter investigation designed to determine the significance of NTM in CF patients were required to demonstrate proficiency in the incorporation of this improved method; this was accomplished by successful decontamination and culture workup of a panel of simulated sputum samples seeded with P. aeruginosa and various NTM. All laboratories successfully recovered NTM from samples with acid-fast bacillus (AFB) smear scores of 3+/4+ (i.e., 2 to 18 or > 18 organisms/field). Low-inoculum samples (1+/2+ AFB smears [2 to 18 organisms in 100 or 10 fields]) were problematic in that processed specimens were often smear and/or culture negative.

Entities:  

Mesh:

Year:  1997        PMID: 9316943      PMCID: PMC230046          DOI: 10.1128/jcm.35.10.2706-2708.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

Review 1.  Microbiology of cystic fibrosis lung infections: themes and issues.

Authors:  J R Govan; J W Nelson
Journal:  J R Soc Med       Date:  1993       Impact factor: 5.344

2.  Specimen contamination in mycobacteriology laboratory detected by pseudo-outbreak of multidrug-resistant tuberculosis: analysis by routine epidemiology and confirmation by molecular technique.

Authors:  R Wurtz; P Demarais; W Trainor; J McAuley; F Kocka; L Mosher; S Dietrich
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

3.  Nontuberculous mycobacteria in adult patients with cystic fibrosis.

Authors:  J M Kilby; P H Gilligan; J R Yankaskas; W E Highsmith; L J Edwards; M R Knowles
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

4.  Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis.

Authors:  S Whittier; R L Hopfer; M R Knowles; P H Gilligan
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

Review 5.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

Review 6.  Evolution of airway microbiology in the infant with cystic fibrosis: role of nonpseudomonal and pseudomonal pathogens.

Authors:  M Rosenfeld; B Ramsey
Journal:  Semin Respir Infect       Date:  1992-09

7.  Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by a target-amplified test system.

Authors:  G E Pfyffer; P Kissling; R Wirth; R Weber
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

8.  Laboratory contamination of Mycobacterium tuberculosis cultures.

Authors:  N E Dunlap; R H Harris; W H Benjamin; J W Harden; D Hafner
Journal:  Am J Respir Crit Care Med       Date:  1995-11       Impact factor: 21.405

9.  Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by Amplicor PCR.

Authors:  D F Moore; J I Curry
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

  9 in total
  15 in total

1.  Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis.

Authors:  Agnès Ferroni; Hoang Vu-Thien; Philippe Lanotte; Muriel Le Bourgeois; Isabelle Sermet-Gaudelus; Brigitte Fauroux; Sophie Marchand; Françoise Varaigne; Patrick Berche; Jean-Louis Gaillard; Catherine Offredo
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Detection of rapidly growing mycobacteria in routine cultures of samples from patients with cystic fibrosis.

Authors:  Charles R Esther; Steven Hoberman; Jason Fine; Sonia Allen; Karissa Culbreath; Kyle Rodino; Alan Kerr; Peter Gilligan
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

3.  Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis.

Authors:  M Sanguinetti; F Ardito; E Fiscarelli; M La Sorda ; P D'Argenio; G Ricciotti; G Fadda
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

4.  Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis.

Authors:  Catherine Pierre-Audigier; Agnès Ferroni; Isabelle Sermet-Gaudelus; Muriel Le Bourgeois; Catherine Offredo; Hoang Vu-Thien; Brigitte Fauroux; Patricia Mariani; Anne Munck; Edouard Bingen; Didier Guillemot; Gilles Quesne; Véronique Vincent; Patrick Berche; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

5.  Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis.

Authors:  Bodil E Jönsson; Marita Gilljam; Anders Lindblad; Malin Ridell; Agnes E Wold; Christina Welinder-Olsson
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

6.  Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation.

Authors:  W Chalermskulrat; N Sood; I P Neuringer; T M Hecker; L Chang; M P Rivera; L J Paradowski; R M Aris
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

7.  Recovery of mycobacteria from patients with cystic fibrosis.

Authors:  F C Bange; P Kirschner; E C Böttger
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

8.  Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis.

Authors:  Charles R Esther; Denise A Esserman; Peter Gilligan; Alan Kerr; Peadar G Noone
Journal:  J Cyst Fibros       Date:  2010-01-13       Impact factor: 5.482

9.  Prevalence of rifampicin resistance tuberculosis among HIV/TB coinfected patients in Benue State, Nigeria.

Authors:  Francis Enenche Ejeh; Ann Undiandeye; Kenneth Okon; Kazeem Haruna Moshood
Journal:  Pan Afr Med J       Date:  2021-02-23

10.  Mycobacterium abscessus and children with cystic fibrosis.

Authors:  Isabelle Sermet-Gaudelus; Muriel Le Bourgeois; Catherine Pierre-Audigier; Catherine Offredo; Didier Guillemot; Sophie Halley; Chantal Akoua-Koffi; Véronique Vincent; Valérie Sivadon-Tardy; Agnès Ferroni; Patrick Berche; Pierre Scheinmann; Gérard Lenoir; Jean-Louis Gaillard
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.